Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 18821432)

1.

Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment.

Rubenstein J, Ferreri AJ, Pittaluga S.

Leuk Lymphoma. 2008;49 Suppl 1:43-51. doi: 10.1080/10428190802311441. Review.

2.

Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.

van der Sanden GA, Schouten LJ, van Dijck JA, van Andel JP, van der Maazen RW, Coebergh JW; Working Group of Specialists in Neuro-Oncology in the Southern and Eastern Netherlands.

Cancer. 2002 Mar 1;94(5):1548-56.

PMID:
11920513
3.

Current status and future of relapsed primary central nervous system lymphoma (PCNSL).

Tyson RM, Siegal T, Doolittle ND, Lacy C, Kraemer DF, Neutwelt EA.

Leuk Lymphoma. 2003 Apr;44(4):627-33.

PMID:
12769339
4.

Primary central nervous system lymphoma.

Abrey LE.

Curr Opin Neurol. 2009 Dec;22(6):675-80. doi: 10.1097/WCO.0b013e328332533b. Review.

PMID:
19741527
5.

[Recent advances in the treatment of primary central nervous system lymphoma].

Nakamaki T.

Brain Nerve. 2014 Aug;66(8):969-79. Review. Japanese.

PMID:
25082318
6.

Current management of primary central nervous system lymphoma.

Schultz CJ, Bovi J.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):666-78. doi: 10.1016/j.ijrobp.2009.10.011. Review.

PMID:
20159361
7.

[Management of primary central nervous system lymphoma].

Gonzalez-Aguilar A, Houillier C, Soussain C, Hoang-Xuan K.

Rev Neurol (Paris). 2011 Oct;167(10):721-8. doi: 10.1016/j.neurol.2011.08.004. Epub 2011 Sep 8. Review. French.

PMID:
21906768
8.

Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.

Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A.

Cancer. 2007 Oct 15;110(8):1803-14.

9.

Primary CNS lymphoma.

Phillips EH, Fox CP, Cwynarski K.

Curr Hematol Malig Rep. 2014 Sep;9(3):243-53. doi: 10.1007/s11899-014-0217-2. Review.

10.

Diagnosis and treatment of primary CNS lymphoma.

Korfel A, Schlegel U.

Nat Rev Neurol. 2013 Jun;9(6):317-27. doi: 10.1038/nrneurol.2013.83. Epub 2013 May 14. Review.

PMID:
23670107
11.

Diagnosis and treatment of primary central nervous system lymphoma.

Gavrilovic IT, Abrey LE.

Curr Oncol Rep. 2005 Jan;7(1):47-54. Review.

PMID:
15610686
12.

Biology and treatment of primary central nervous system lymphoma.

Algazi AP, Kadoch C, Rubenstein JL.

Neurotherapeutics. 2009 Jul;6(3):587-97. doi: 10.1016/j.nurt.2009.04.013. Review.

PMID:
19560747
13.

Primary central nervous system lymphoma: a profile of 26 cases from Western India.

Agarwal PA, Menon S, Smruti BK, Singhal BS.

Neurol India. 2009 Nov-Dec;57(6):756-63. doi: 10.4103/0028-3886.59472.

14.

Primary central nervous system lymphoma.

Gavrilovic IT, Abrey LE.

Curr Oncol Rep. 2004 Sep;6(5):388-95. Review.

PMID:
15291982
15.

Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.

Siegal T.

J Clin Neurosci. 2014 May;21(5):709-15. doi: 10.1016/j.jocn.2014.02.002. Review.

PMID:
24725453
16.

Primary central nervous system lymphoma.

Mohile NA, Abrey LE.

Neurol Clin. 2007 Nov;25(4):1193-207, xi. Review.

PMID:
17964031
17.

Primary CNS lymphoma.

Gerstner E, Batchelor T.

Expert Rev Anticancer Ther. 2007 May;7(5):689-700. Review.

PMID:
17492932
18.

Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.

Ferreri AJ, Assanelli A, Crocchiolo R, Ciceri F.

Hematol Oncol. 2009 Jun;27(2):61-70. doi: 10.1002/hon.881. Review.

PMID:
19247977
19.

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.

Cheng T, Forsyth P, Chaudhry A, Morris D, Gl├╝ck S, Russell JA, Stewart DA.

Bone Marrow Transplant. 2003 Apr;31(8):679-85.

PMID:
12692608
20.

Treatment options for central nervous system lymphomas in immunocompetent patients.

Jahnke K, Thiel E.

Expert Rev Neurother. 2009 Oct;9(10):1497-509. doi: 10.1586/ern.09.100.

PMID:
19831839
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk